3-aminobenzamide has been researched along with Ventricular Dysfunction, Left in 1 studies
Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Szabó, G | 1 |
| Soós, P | 1 |
| Heger, U | 1 |
| Flechtenmacher, C | 1 |
| Bährle, S | 1 |
| Zsengellér, Z | 1 |
| Szabó, C | 1 |
| Hagl, S | 1 |
1 other study available for 3-aminobenzamide and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Poly(ADP-ribose) polymerase inhibition attenuates biventricular reperfusion injury after orthotopic heart transplantation.
Topics: Animals; Coronary Circulation; Dogs; Endothelium, Vascular; Heart Transplantation; Heart Ventricles; | 2005 |